CD8A and colorectal carcinoma: showed intra-tumoural injection of the TLR-9 agonist lefitolimod led to remodelling of the TME to a “hot” phenotype in mouse CRC models – with CD8 T cell influx, an increase in the CD8:Treg ratio and a greater proportion of M1-polarised macrophages (126).